Meningococcal is a deadly disease is not taken care of immediately. The disease is majorly present in the teenage group and is caused by bacterial meningitis. It is basically an inflammation lining of the brain and spinal cord. There are three types of vaccines available for meningitis one of which is sold as menomune, menactra, and Bexsero and Trumenba. Annually, 2000-2600 teenagers are affected from this disease. Among these, one third are young adults, other 10% of the population from this disease are probable to lose their lives even after taking the antibiotic treatment. The remaining 20% of the population with this disease may experience permanent side-effects, such as brain damage and hearing loss.
Major Key Players of the Meningococcal Vaccines Market are:GlaxoSmithKline , Sanofi, Pfizer, Serum Institute of India Pvt. Ltd, Nuron Biotech Inc., BIO-MED, Hualan Biological Engineering Inc, Walvax Biotechnology Co., Ltd. and other key players (if any) among others.
Read More @ https://www.openpr.com/news/2054013/meningococcal-vaccines-market-development-trends-key
Major Key Players of the Meningococcal Vaccines Market are:GlaxoSmithKline , Sanofi, Pfizer, Serum Institute of India Pvt. Ltd, Nuron Biotech Inc., BIO-MED, Hualan Biological Engineering Inc, Walvax Biotechnology Co., Ltd. and other key players (if any) among others.
Read More @ https://www.openpr.com/news/2054013/meningococcal-vaccines-market-development-trends-key
No comments:
Post a Comment